Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Lower Costs, More Cures Act of 2019
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to the HHS Rebate rule; general issues related to drug pricing; issues related to cosmetic regulations; issues related to insulin pricing;issues related to s.102 "Prescription Drug Price Relief Act of 2019"; issues related to International Reference pricing; issues related to OTC Monograph Reform; issues related to prescription to over-the-counter switch; issues related to compulsory licensing; issues related to Drug Importation;issues related to H.R. 3 "Lower Drug Costs Now Act of 2019"; issues related to S. 2740 "Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019"; issues related to influenza vaccines; issues related to the Executive Order on Flu; and issues related to H.R. 19 "Lower Costs, More Cures Act of 2019" .
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SANOFI US SERVICES INC via SANOFI US SERVICES INC.
2019 · fourth_quarter · Q4
Issues related to the HHS Rebate rule; general issues related to drug pricing; issues related to cosmetic regulations; issues related to insulin pricing;issues related to s.102 "Prescription Drug Price Relief Act of 2019"; issues related to International Reference pricing; issues related to OTC Monograph Reform; issues related to prescription to over-the-counter switch; issues related to compulsory licensing; issues related to Drug Importation;issues related to H.R. 3 "Lower Drug Costs Now Act of 2019"; issues related to S. 2740 "Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019"; issues related to influenza vaccines; issues related to the Executive Order on Flu; and issues related to H.R. 19 "Lower Costs, More Cures Act of 2019" .
Source: Senate LDA
Issues related to the HHS Rebate rule; general issues related to drug pricing; issues related to cosmetic regulations; issues related to insulin pricing; issues related to seasonal influenza vaccination; issues related to Drug Importation;issues related to s.102 "Prescription Drug Price Relief Act of 2019"; issues related to International Reference pricing; issues related to OTC Monograph Reform; issues related to Arbitration; issues related to H.R. 2087 "Drug Price Transparency Act"; issues related to S.977 "Medicare Drug Price Negotiation Act"; issues related to S.1379 " Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019"; and issues related to H.R. 269 "Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019:.
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to the HHS Rebate rule; general issues related to drug pricing; issues related to cosmetic regulations; issues related to insulin pricing; issues related to seasonal influenza vaccination; issues related to Drug Importation;issues related to s.102 "Prescription Drug Price Relief Act of 2019"; issues related to International Reference pricing; issues related to OTC Monograph Reform; issues related to Arbitration; issues related to H.R. 2087 "Drug Price Transparency Act"; issues related to S.977 "Medicare Drug Price Negotiation Act"; issues related to S.1379 " Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019"; and issues related to H.R. 269 "Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019:.
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to the HHS Rebate rule; general issues related to drug pricing; issues related to cosmetic regulations; issues related to insulin pricing; issues related to seasonal influenza vaccination; issues related to Drug Importation; issues related to S. 97 " Affordable and Safe Prescription Drug Importation Act"; issues related to s.102 "Prescription Drug Price Relief Act of 2019"; issues related to International Reference pricing; issues related to dietary supplements; and issues related to H.R. 269 "Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019:.
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to the HHS Rebate rule; general issues related to drug pricing; issues related to cosmetic regulations; issues related to insulin pricing;issues related to s.102 "Prescription Drug Price Relief Act of 2019"; issues related to International Reference pricing; issues related to OTC Monograph Reform; issues related to Arbitration;; issues related to S.1379 " Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019"; issues related to H.R. 269 "Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019; issues related to prescription to over-the-counter switch; issues related to compulsory licensing; issues related to Drug Importation; and issues related to H.R. 3 "Lower Drug Costs Now Act of 2019".
Elijah E. Cummings Lower Drug Costs Now Act
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to the HHS Rebate rule; general issues related to drug pricing; issues related to cosmetic regulations; issues related to insulin pricing;issues related to s.102 "Prescription Drug Price Relief Act of 2019"; issues related to International Reference pricing; issues related to OTC Monograph Reform; issues related to Arbitration;; issues related to S.1379 " Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019"; issues related to H.R. 269 "Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019; issues related to prescription to over-the-counter switch; issues related to compulsory licensing; issues related to Drug Importation; and issues related to H.R. 3 "Lower Drug Costs Now Act of 2019".
Elijah E. Cummings Lower Drug Costs Now Act
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to the HHS Rebate rule; general issues related to drug pricing; issues related to cosmetic regulations; issues related to insulin pricing;issues related to s.102 "Prescription Drug Price Relief Act of 2019"; issues related to International Reference pricing; issues related to OTC Monograph Reform; issues related to prescription to over-the-counter switch; issues related to compulsory licensing; issues related to Drug Importation;issues related to H.R. 3 "Lower Drug Costs Now Act of 2019"; issues related to S. 2740 "Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019"; issues related to influenza vaccines; issues related to the Executive Order on Flu; and issues related to H.R. 19 "Lower Costs, More Cures Act of 2019" .
Prescription Drug Price Relief Act of 2019
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to the HHS Rebate rule; general issues related to drug pricing; issues related to cosmetic regulations; issues related to insulin pricing;issues related to s.102 "Prescription Drug Price Relief Act of 2019"; issues related to International Reference pricing; issues related to OTC Monograph Reform; issues related to prescription to over-the-counter switch; issues related to compulsory licensing; issues related to Drug Importation;issues related to H.R. 3 "Lower Drug Costs Now Act of 2019"; issues related to S. 2740 "Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019"; issues related to influenza vaccines; issues related to the Executive Order on Flu; and issues related to H.R. 19 "Lower Costs, More Cures Act of 2019" .
Prescription Drug Price Relief Act of 2019
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to the HHS Rebate rule; general issues related to drug pricing; issues related to cosmetic regulations; issues related to insulin pricing; issues related to seasonal influenza vaccination; issues related to Drug Importation;issues related to s.102 "Prescription Drug Price Relief Act of 2019"; issues related to International Reference pricing; issues related to OTC Monograph Reform; issues related to Arbitration; issues related to H.R. 2087 "Drug Price Transparency Act"; issues related to S.977 "Medicare Drug Price Negotiation Act"; issues related to S.1379 " Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019"; and issues related to H.R. 269 "Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019:.
Prescription Drug Price Relief Act of 2019
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to the HHS Rebate rule; general issues related to drug pricing; issues related to cosmetic regulations; issues related to insulin pricing; issues related to seasonal influenza vaccination; issues related to Drug Importation; issues related to S. 97 " Affordable and Safe Prescription Drug Importation Act"; issues related to s.102 "Prescription Drug Price Relief Act of 2019"; issues related to International Reference pricing; issues related to dietary supplements; and issues related to H.R. 269 "Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019:.
Prescription Drug Price Relief Act of 2019
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to the HHS Rebate rule; general issues related to drug pricing; issues related to cosmetic regulations; issues related to insulin pricing;issues related to s.102 "Prescription Drug Price Relief Act of 2019"; issues related to International Reference pricing; issues related to OTC Monograph Reform; issues related to Arbitration;; issues related to S.1379 " Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019"; issues related to H.R. 269 "Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019; issues related to prescription to over-the-counter switch; issues related to compulsory licensing; issues related to Drug Importation; and issues related to H.R. 3 "Lower Drug Costs Now Act of 2019".
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to the HHS Rebate rule; general issues related to drug pricing; issues related to cosmetic regulations; issues related to insulin pricing;issues related to s.102 "Prescription Drug Price Relief Act of 2019"; issues related to International Reference pricing; issues related to OTC Monograph Reform; issues related to Arbitration;; issues related to S.1379 " Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019"; issues related to H.R. 269 "Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019; issues related to prescription to over-the-counter switch; issues related to compulsory licensing; issues related to Drug Importation; and issues related to H.R. 3 "Lower Drug Costs Now Act of 2019".
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to the HHS Rebate rule; general issues related to drug pricing; issues related to cosmetic regulations; issues related to insulin pricing; issues related to seasonal influenza vaccination; issues related to Drug Importation;issues related to s.102 "Prescription Drug Price Relief Act of 2019"; issues related to International Reference pricing; issues related to OTC Monograph Reform; issues related to Arbitration; issues related to H.R. 2087 "Drug Price Transparency Act"; issues related to S.977 "Medicare Drug Price Negotiation Act"; issues related to S.1379 " Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019"; and issues related to H.R. 269 "Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019:.
Affordable Prescriptions for Patients Act of 2019
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to Compulsory Licensing; issues related to drug patents; and issues related to S. 1416 "Affordable Prescription for Patients Act of 2019".
Issues related to Compulsory Licensing; issues related to drug patents; and issues related to S. 2082 "Support Technology and Research for Our Nation's Growth and Economic Resilience Patents Act of 2019".
Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to the HHS Rebate rule; general issues related to drug pricing; issues related to cosmetic regulations; issues related to insulin pricing;issues related to s.102 "Prescription Drug Price Relief Act of 2019"; issues related to International Reference pricing; issues related to OTC Monograph Reform; issues related to prescription to over-the-counter switch; issues related to compulsory licensing; issues related to Drug Importation;issues related to H.R. 3 "Lower Drug Costs Now Act of 2019"; issues related to S. 2740 "Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019"; issues related to influenza vaccines; issues related to the Executive Order on Flu; and issues related to H.R. 19 "Lower Costs, More Cures Act of 2019" .
Hatch-Waxman Integrity Act of 2019
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to Compulsory Licensing; issues related to drug patents; and issues related to S.344 "Hatch-Waxman Integrity Act of 2019".
Affordable and Safe Prescription Drug Importation Act
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to the HHS Rebate rule; general issues related to drug pricing; issues related to cosmetic regulations; issues related to insulin pricing; issues related to seasonal influenza vaccination; issues related to Drug Importation; issues related to S. 97 " Affordable and Safe Prescription Drug Importation Act"; issues related to s.102 "Prescription Drug Price Relief Act of 2019"; issues related to International Reference pricing; issues related to dietary supplements; and issues related to H.R. 269 "Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019:.
Transparent Drug Pricing Act of 2019
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to the HHS Rebate rule; general issues related to drug pricing; issues related to cosmetic regulations; issues related to insulin pricing; issues related to seasonal influenza vaccination; issues related to Drug Importation;issues related to s.102 "Prescription Drug Price Relief Act of 2019"; issues related to International Reference pricing; issues related to OTC Monograph Reform; issues related to Arbitration; issues related to H.R. 2087 "Drug Price Transparency Act"; issues related to S.977 "Medicare Drug Price Negotiation Act"; issues related to S.1379 " Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019"; and issues related to H.R. 269 "Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019:.
Medicare Drug Price Negotiation Act
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to S.99 "Medicare Drug Price Negotiation Act"; issues related to blended ASP authorized generics; issues related to Medicaid AMP CAP; and issues related to international price index.
Consolidated Appropriations Act, 2018
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to HR1625 "Consolidated Appropriations Act of 2018"; issues related to HR1892 "Bipartisan Budget Act of 2018"; issues related to National Institute of Health (NIH) funding; and issues related to Biomedical Advanced Research and Development Authority (BARDA)".
Bipartisan Budget Act of 2018
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to HR1625 "Consolidated Appropriations Act of 2018"; issues related to HR1892 "Bipartisan Budget Act of 2018"; issues related to National Institute of Health (NIH) funding; and issues related to Biomedical Advanced Research and Development Authority (BARDA)".
Bipartisan Budget Act of 2018
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to Biomedical Advanced Research and Development Authority (BARDA)" funding; and issues related to HR1892 "Bipartisan Budget Act of 2018.
Bipartisan Budget Act of 2018
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to Biomedical Advanced Research and Development Authority (BARDA)" funding;and Part D and other issues related to HR1892 "Bipartisan Budget Act of 2018.
Bipartisan Budget Act of 2018
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to Biomedical Advanced Research and Development Authority (BARDA)" funding;and issues related to HR1892 "Bipartisan Budget Act of 2018.
Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing;issues related H.R. 6378 "Pandemic and All Hazards Preparedness (PAHPA)Advancing Innovation Act"; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to 340B Reform; issues related to Drug Importation; issues related to vaccine safety;issues related to HR5333 "Over-the-Counter Monograph Safety, Innovation, and reform Act of 2018; issues related to HR2212 "CREATES Act of 2017";issues related to HR 2439 "Fair Accountability and Innovation Research Drug Act of 2017"; issues related S. 2852 "Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPA) of 2018"; issues related to PAHPA reauthorization; and issues related to S.2465 "Sickle Cell Disease and other Heritable Blood Disorders Research, Surveillance, Prevention and Treatment Act of 2018"
Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing;issues related to Pandemic and All Hazards Preparedness (PAHPA)reauthorization; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to Right to Try; issues related to 340B Reform; issues related to Drug Importation; issues related to vaccine safety;issues related to HR5333 "Over-the-Counter Monograph Safety, Innovation, and reform Act of 2018; issues related to FDA User Fee Reauthorization; issues related to HR2212 "CREATES Act of 2017"; and issues related to HR 2439 "Fair Accountability and Innovation Research Drug Act of 2017".
Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing;issues related H.R. 6378 "Pandemic and All Hazards Preparedness (PAHPA)Advancing Innovation Act"; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to 340B Reform; issues related to Drug Importation; issues related to vaccine safety;issues related to HR5333 "Over-the-Counter Monograph Safety, Innovation, and reform Act of 2018; issues related to HR2212 "CREATES Act of 2017";issues related to HR 2439 "Fair Accountability and Innovation Research Drug Act of 2017"; issues related to Medicare rebate disclosure; issues related to S. 2852 "Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018"; issues related to S. 297 "Increasing Competition in Pharmaceuticals Act"; and issues related to S.2465 "Sickle Cell Disease and other Heritable Blood Disorders Research, Surveillance, Prevention and Treatment Act of 2018"
Fair Accountability and Innovative Research Drug Pricing Act of 2017
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing;issues related H.R. 6378 "Pandemic and All Hazards Preparedness (PAHPA)Advancing Innovation Act"; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to 340B Reform; issues related to Drug Importation; issues related to vaccine safety;issues related to HR5333 "Over-the-Counter Monograph Safety, Innovation, and reform Act of 2018; issues related to HR2212 "CREATES Act of 2017";issues related to HR 2439 "Fair Accountability and Innovation Research Drug Act of 2017"; issues related to Medicare rebate disclosure; issues related to S. 2852 "Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018"; issues related to S. 297 "Increasing Competition in Pharmaceuticals Act"; and issues related to S.2465 "Sickle Cell Disease and other Heritable Blood Disorders Research, Surveillance, Prevention and Treatment Act of 2018"
Fair Accountability and Innovative Research Drug Pricing Act of 2017
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing;issues related to Pandemic and All Hazards Preparedness (PAHPA)reauthorization; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to Right to Try; issues related to 340B Reform; issues related to Drug Importation; issues related to vaccine safety;issues related to HR5333 "Over-the-Counter Monograph Safety, Innovation, and reform Act of 2018; issues related to FDA User Fee Reauthorization; issues related to HR2212 "CREATES Act of 2017"; and issues related to HR 2439 "Fair Accountability and Innovation Research Drug Act of 2017".
Fair Accountability and Innovative Research Drug Pricing Act of 2017
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing;issues related H.R. 6378 "Pandemic and All Hazards Preparedness (PAHPA)Advancing Innovation Act"; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to 340B Reform; issues related to Drug Importation; issues related to vaccine safety;issues related to HR5333 "Over-the-Counter Monograph Safety, Innovation, and reform Act of 2018; issues related to HR2212 "CREATES Act of 2017";issues related to HR 2439 "Fair Accountability and Innovation Research Drug Act of 2017"; issues related S. 2852 "Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPA) of 2018"; issues related to PAHPA reauthorization; and issues related to S.2465 "Sickle Cell Disease and other Heritable Blood Disorders Research, Surveillance, Prevention and Treatment Act of 2018"
National Defense Authorization Act for Fiscal Year 2018
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues with march-in rights within H.R 2810 National Defense Authorization Act for Fiscal Year 2018; issues related to Compulsory Licensing.
Vaccine Access Improvement Act of 2018
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to H.R.4993 "Vaccine Access Improvement Act of 2018"; and issues related to Orphan Drug Tax Credit
Vaccine Access Improvement Act of 2018
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to Border adjustability tax; issues related to H.R.4993; issues related to H.R.4993 "Vaccine Access Improvement Act of 2018"; and issues related to Orphan Drug Tax Credit
Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing;issues related H.R. 6378 "Pandemic and All Hazards Preparedness (PAHPA)Advancing Innovation Act"; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to 340B Reform; issues related to Drug Importation; issues related to vaccine safety;issues related to HR5333 "Over-the-Counter Monograph Safety, Innovation, and reform Act of 2018; issues related to HR2212 "CREATES Act of 2017";issues related to HR 2439 "Fair Accountability and Innovation Research Drug Act of 2017"; issues related to Medicare rebate disclosure; issues related to S. 2852 "Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018"; issues related to S. 297 "Increasing Competition in Pharmaceuticals Act"; and issues related to S.2465 "Sickle Cell Disease and other Heritable Blood Disorders Research, Surveillance, Prevention and Treatment Act of 2018"
Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing;issues related to Pandemic and All Hazards Preparedness (PAHPA)reauthorization; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to Right to Try; issues related to 340B Reform; issues related to Drug Importation; issues related to vaccine safety;issues related to HR5333 "Over-the-Counter Monograph Safety, Innovation, and reform Act of 2018; issues related to FDA User Fee Reauthorization; issues related to HR2212 "CREATES Act of 2017"; and issues related to HR 2439 "Fair Accountability and Innovation Research Drug Act of 2017".
Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing;issues related H.R. 6378 "Pandemic and All Hazards Preparedness (PAHPA)Advancing Innovation Act"; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to 340B Reform; issues related to Drug Importation; issues related to vaccine safety;issues related to HR5333 "Over-the-Counter Monograph Safety, Innovation, and reform Act of 2018; issues related to HR2212 "CREATES Act of 2017";issues related to HR 2439 "Fair Accountability and Innovation Research Drug Act of 2017"; issues related S. 2852 "Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPA) of 2018"; issues related to PAHPA reauthorization; and issues related to S.2465 "Sickle Cell Disease and other Heritable Blood Disorders Research, Surveillance, Prevention and Treatment Act of 2018"
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing;issues related H.R. 6378 "Pandemic and All Hazards Preparedness (PAHPA)Advancing Innovation Act"; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to 340B Reform; issues related to Drug Importation; issues related to vaccine safety;issues related to HR5333 "Over-the-Counter Monograph Safety, Innovation, and reform Act of 2018; issues related to HR2212 "CREATES Act of 2017";issues related to HR 2439 "Fair Accountability and Innovation Research Drug Act of 2017"; issues related S. 2852 "Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPA) of 2018"; issues related to PAHPA reauthorization; and issues related to S.2465 "Sickle Cell Disease and other Heritable Blood Disorders Research, Surveillance, Prevention and Treatment Act of 2018"
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing;issues related H.R. 6378 "Pandemic and All Hazards Preparedness (PAHPA)Advancing Innovation Act"; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to 340B Reform; issues related to Drug Importation; issues related to vaccine safety;issues related to HR5333 "Over-the-Counter Monograph Safety, Innovation, and reform Act of 2018; issues related to HR2212 "CREATES Act of 2017";issues related to HR 2439 "Fair Accountability and Innovation Research Drug Act of 2017"; issues related to Medicare rebate disclosure; issues related to S. 2852 "Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018"; issues related to S. 297 "Increasing Competition in Pharmaceuticals Act"; and issues related to S.2465 "Sickle Cell Disease and other Heritable Blood Disorders Research, Surveillance, Prevention and Treatment Act of 2018"
Over-the-Counter Drug Safety, Innovation, and Reform Act
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing; and issues related to Pandemic and All Hazards Preparedness (PAHPA)reauthorization; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to Right to Try.
Over-the-Counter Drug Safety, Innovation, and Reform Act
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing;issues related to Pandemic and All Hazards Preparedness (PAHPA)reauthorization; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to Right to Try; issues related to 340B Reform; issues related to Drug Importation; issues related to vaccine safety;issues related to HR5333 "Over-the-Counter Monograph Safety, Innovation, and reform Act of 2018; issues related to FDA User Fee Reauthorization; issues related to HR2212 "CREATES Act of 2017"; and issues related to HR 2439 "Fair Accountability and Innovation Research Drug Act of 2017".
Over-the-Counter Drug Safety, Innovation, and Reform Act
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing;issues related H.R. 6378 "Pandemic and All Hazards Preparedness (PAHPA)Advancing Innovation Act"; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to 340B Reform; issues related to Drug Importation; issues related to vaccine safety;issues related to HR5333 "Over-the-Counter Monograph Safety, Innovation, and reform Act of 2018; issues related to HR2212 "CREATES Act of 2017";issues related to HR 2439 "Fair Accountability and Innovation Research Drug Act of 2017"; issues related S. 2852 "Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPA) of 2018"; issues related to PAHPA reauthorization; and issues related to S.2465 "Sickle Cell Disease and other Heritable Blood Disorders Research, Surveillance, Prevention and Treatment Act of 2018"
Over-the-Counter Drug Safety, Innovation, and Reform Act
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing;issues related H.R. 6378 "Pandemic and All Hazards Preparedness (PAHPA)Advancing Innovation Act"; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to 340B Reform; issues related to Drug Importation; issues related to vaccine safety;issues related to HR5333 "Over-the-Counter Monograph Safety, Innovation, and reform Act of 2018; issues related to HR2212 "CREATES Act of 2017";issues related to HR 2439 "Fair Accountability and Innovation Research Drug Act of 2017"; issues related to Medicare rebate disclosure; issues related to S. 2852 "Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018"; issues related to S. 297 "Increasing Competition in Pharmaceuticals Act"; and issues related to S.2465 "Sickle Cell Disease and other Heritable Blood Disorders Research, Surveillance, Prevention and Treatment Act of 2018"
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing;issues related H.R. 6378 "Pandemic and All Hazards Preparedness (PAHPA)Advancing Innovation Act"; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to 340B Reform; issues related to Drug Importation; issues related to vaccine safety;issues related to HR5333 "Over-the-Counter Monograph Safety, Innovation, and reform Act of 2018; issues related to HR2212 "CREATES Act of 2017";issues related to HR 2439 "Fair Accountability and Innovation Research Drug Act of 2017"; issues related to Medicare rebate disclosure; issues related to S. 2852 "Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018"; issues related to S. 297 "Increasing Competition in Pharmaceuticals Act"; and issues related to S.2465 "Sickle Cell Disease and other Heritable Blood Disorders Research, Surveillance, Prevention and Treatment Act of 2018"
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing;issues related H.R. 6378 "Pandemic and All Hazards Preparedness (PAHPA)Advancing Innovation Act"; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to 340B Reform; issues related to Drug Importation; issues related to vaccine safety;issues related to HR5333 "Over-the-Counter Monograph Safety, Innovation, and reform Act of 2018; issues related to HR2212 "CREATES Act of 2017";issues related to HR 2439 "Fair Accountability and Innovation Research Drug Act of 2017"; issues related S. 2852 "Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPA) of 2018"; issues related to PAHPA reauthorization; and issues related to S.2465 "Sickle Cell Disease and other Heritable Blood Disorders Research, Surveillance, Prevention and Treatment Act of 2018"
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing;issues related H.R. 6378 "Pandemic and All Hazards Preparedness (PAHPA)Advancing Innovation Act"; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to 340B Reform; issues related to Drug Importation; issues related to vaccine safety;issues related to HR5333 "Over-the-Counter Monograph Safety, Innovation, and reform Act of 2018; issues related to HR2212 "CREATES Act of 2017";issues related to HR 2439 "Fair Accountability and Innovation Research Drug Act of 2017"; issues related to Medicare rebate disclosure; issues related to S. 2852 "Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018"; issues related to S. 297 "Increasing Competition in Pharmaceuticals Act"; and issues related to S.2465 "Sickle Cell Disease and other Heritable Blood Disorders Research, Surveillance, Prevention and Treatment Act of 2018"
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing;issues related H.R. 6378 "Pandemic and All Hazards Preparedness (PAHPA)Advancing Innovation Act"; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to 340B Reform; issues related to Drug Importation; issues related to vaccine safety;issues related to HR5333 "Over-the-Counter Monograph Safety, Innovation, and reform Act of 2018; issues related to HR2212 "CREATES Act of 2017";issues related to HR 2439 "Fair Accountability and Innovation Research Drug Act of 2017"; issues related S. 2852 "Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPA) of 2018"; issues related to PAHPA reauthorization; and issues related to S.2465 "Sickle Cell Disease and other Heritable Blood Disorders Research, Surveillance, Prevention and Treatment Act of 2018"
Increasing Competition in Pharmaceuticals Act
Client: SANOFI US SERVICES INC · Firm: SANOFI US SERVICES INC.
Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing;issues related H.R. 6378 "Pandemic and All Hazards Preparedness (PAHPA)Advancing Innovation Act"; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to 340B Reform; issues related to Drug Importation; issues related to vaccine safety;issues related to HR5333 "Over-the-Counter Monograph Safety, Innovation, and reform Act of 2018; issues related to HR2212 "CREATES Act of 2017";issues related to HR 2439 "Fair Accountability and Innovation Research Drug Act of 2017"; issues related to Medicare rebate disclosure; issues related to S. 2852 "Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018"; issues related to S. 297 "Increasing Competition in Pharmaceuticals Act"; and issues related to S.2465 "Sickle Cell Disease and other Heritable Blood Disorders Research, Surveillance, Prevention and Treatment Act of 2018"
Issues related to USMCA- United States- Mexico-Canada Agreement.
Issues related to BARDA/Biodefense appropriations
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC via SANOFI US SERVICES INC.
2019 · third_quarter · Q3
Issues related to Compulsory Licensing; issues related to drug patents; and issues related to S. 2082 "Support Technology and Research for Our Nation's Growth and Economic Resilience Patents Act of 2019".
Issues related to the HHS Rebate rule; general issues related to drug pricing; issues related to cosmetic regulations; issues related to insulin pricing;issues related to s.102 "Prescription Drug Price Relief Act of 2019"; issues related to International Reference pricing; issues related to OTC Monograph Reform; issues related to Arbitration;; issues related to S.1379 " Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019"; issues related to H.R. 269 "Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019; issues related to prescription to over-the-counter switch; issues related to compulsory licensing; issues related to Drug Importation; and issues related to H.R. 3 "Lower Drug Costs Now Act of 2019".
Issues related to blended ASP authorized generics; issues related to Medicaid AMP CAP; issues related to international price index; and issues related to Medicare Part D.
Issues related to USMCA- United States- Mexico-Canada Agreement.
Filing targets: Administration for Children & Families (ACF), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
SANOFI US SERVICES INC via SANOFI US SERVICES INC.
2019 · second_quarter · Q2
Issues related to Compulsory Licensing; issues related to drug patents; and issues related to S. 1416 "Affordable Prescription for Patients Act of 2019".
Issues related to the HHS Rebate rule; general issues related to drug pricing; issues related to cosmetic regulations; issues related to insulin pricing; issues related to seasonal influenza vaccination; issues related to Drug Importation;issues related to s.102 "Prescription Drug Price Relief Act of 2019"; issues related to International Reference pricing; issues related to OTC Monograph Reform; issues related to Arbitration; issues related to H.R. 2087 "Drug Price Transparency Act"; issues related to S.977 "Medicare Drug Price Negotiation Act"; issues related to S.1379 " Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019"; and issues related to H.R. 269 "Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019:.
Issues related to S.99 "Medicare Drug Price Negotiation Act"; issues related to blended ASP authorized generics; issues related to Medicaid AMP CAP; and issues related to international price index.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SANOFI US SERVICES INC via SANOFI US SERVICES INC.
2019 · first_quarter · Q1
Issues related to Compulsory Licensing; issues related to drug patents; and issues related to S.344 "Hatch-Waxman Integrity Act of 2019".
Issues related to the HHS Rebate rule; general issues related to drug pricing; issues related to cosmetic regulations; issues related to insulin pricing; issues related to seasonal influenza vaccination; issues related to Drug Importation; issues related to S. 97 " Affordable and Safe Prescription Drug Importation Act"; issues related to s.102 "Prescription Drug Price Relief Act of 2019"; issues related to International Reference pricing; issues related to dietary supplements; and issues related to H.R. 269 "Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019:.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC via SANOFI US SERVICES INC.
2018 · fourth_quarter · Q4
Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing;issues related H.R. 6378 "Pandemic and All Hazards Preparedness (PAHPA)Advancing Innovation Act"; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to 340B Reform; issues related to Drug Importation; issues related to vaccine safety;issues related to HR5333 "Over-the-Counter Monograph Safety, Innovation, and reform Act of 2018; issues related to HR2212 "CREATES Act of 2017";issues related to HR 2439 "Fair Accountability and Innovation Research Drug Act of 2017"; issues related S. 2852 "Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPA) of 2018"; issues related to PAHPA reauthorization; and issues related to S.2465 "Sickle Cell Disease and other Heritable Blood Disorders Research, Surveillance, Prevention and Treatment Act of 2018"
Issues related to H.R.4993 "Vaccine Access Improvement Act of 2018"; and issues related to Orphan Drug Tax Credit
Issues related to Compulsory Licensing.
Issues related to Biomedical Advanced Research and Development Authority (BARDA)" funding; and issues related to HR1892 "Bipartisan Budget Act of 2018.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE
SANOFI US SERVICES INC via SANOFI US SERVICES INC.
2018 · third_quarter · Q3
Issues related to Biomedical Advanced Research and Development Authority (BARDA)" funding;and Part D and other issues related to HR1892 "Bipartisan Budget Act of 2018.
Issues related to Border adjustability tax; issues related to H.R.4993; issues related to H.R.4993 "Vaccine Access Improvement Act of 2018"; and issues related to Orphan Drug Tax Credit
Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing;issues related H.R. 6378 "Pandemic and All Hazards Preparedness (PAHPA)Advancing Innovation Act"; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to 340B Reform; issues related to Drug Importation; issues related to vaccine safety;issues related to HR5333 "Over-the-Counter Monograph Safety, Innovation, and reform Act of 2018; issues related to HR2212 "CREATES Act of 2017";issues related to HR 2439 "Fair Accountability and Innovation Research Drug Act of 2017"; issues related to Medicare rebate disclosure; issues related to S. 2852 "Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018"; issues related to S. 297 "Increasing Competition in Pharmaceuticals Act"; and issues related to S.2465 "Sickle Cell Disease and other Heritable Blood Disorders Research, Surveillance, Prevention and Treatment Act of 2018"
SANOFI US SERVICES INC via SANOFI US SERVICES INC.
2018 · second_quarter · Q2
Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing;issues related to Pandemic and All Hazards Preparedness (PAHPA)reauthorization; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to Right to Try; issues related to 340B Reform; issues related to Drug Importation; issues related to vaccine safety;issues related to HR5333 "Over-the-Counter Monograph Safety, Innovation, and reform Act of 2018; issues related to FDA User Fee Reauthorization; issues related to HR2212 "CREATES Act of 2017"; and issues related to HR 2439 "Fair Accountability and Innovation Research Drug Act of 2017".
Issues related to the repeal and non-interference in Part D.
SANOFI US SERVICES INC via SANOFI US SERVICES INC.
2018 · first_quarter · Q1
Issues related to S.2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act; general issues related to drug pricing;issues related to cosmetic regulations; issues related to insulin pricing; and issues related to Pandemic and All Hazards Preparedness (PAHPA)reauthorization; issues related to Medicare Part D; issues related to flu and Veterans Affairs; issues related to seasonal influenza vaccination; issues related to Right to Try.
Issues related to HR1625 "Consolidated Appropriations Act of 2018"; issues related to HR1892 "Bipartisan Budget Act of 2018"; issues related to National Institute of Health (NIH) funding; and issues related to Biomedical Advanced Research and Development Authority (BARDA)".
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues with march-in rights within H.R 2810 National Defense Authorization Act for Fiscal Year 2018; issues related to Compulsory Licensing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Biomedical Advanced Research and Development Authority (BARDA)" funding;and issues related to HR1892 "Bipartisan Budget Act of 2018.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE